Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Masumi Aiso"'
Publikováno v:
Medical Oncology and Tumor Pharmacotherapy. 9:191-197
Tumor necrosis factor-alpha (TNF-alpha) production by unstimulated and lipopolysaccharide (LPS)-stimulated peripheral monocytes has been studied in 17 acute myeloid leukemia (AML) patients, 54 AML patients in complete remission (AML-CR), 9 acute lymp
Autor:
Yoshihiro Matsukawa, Jin Takeuchi, Takashi Horie, Masumi Aiso, Yoku Kitami, Ohshima T, Takashi Hayama, Teruhisa Hagiwara
Publikováno v:
Acta haematologica. 90(3)
A 41-year-old patient with chronic myelogenous leukemia in the accelerated phase was treated with mitoxantrone. She developed pyrexia 7 days after receiving the third administration of mitoxantrone. After 3 more days, she experienced dry cough and dy
Autor:
Masaaki Kawamura, Takashi Horie, Yoshikazu Iizuka, Mineo Kanemaru, Akira Horikoshi, Ohshima T, Hideaki Mizoguchi, Kazuo Oshimi, Jin Takeuchi, Masumi Aiso
Publikováno v:
Leukemia research. 16(6-7)
The cell surface markers on the leukemic cells of 76 patients with adult acute myeloid leukemia (AML) have been analyzed by indirect immunofluorescence, and the presence of CD56+ leukemic cells was detected in ten of these patients. Four of these 10
Publikováno v:
Medical Oncology and Tumor Pharmacotherapy. 9
We have measured the serum levels of soluble CD4, CD8 and IL-2R in 43 patients with AML in complete remission (AML-CR). The sCD8 levels of AML-CR patients (443.9 +/- 224.4 u/ml) were significantly high as compared to that of the normal controls (177.